Pharmacyte Biotech Stock Probability of Future Stock Price Finishing Over 0.0
PharmaCyte Biotech's future price is the expected price of PharmaCyte Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of PharmaCyte Biotech performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Please specify PharmaCyte Biotech's target price for which you would like PharmaCyte Biotech odds to be computed.
PharmaCyte |
PharmaCyte Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PharmaCyte Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PharmaCyte Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PharmaCyte Biotech is not yet fully synchronised with the market data | |
| PharmaCyte Biotech has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (4.32 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PharmaCyte Biotech currently holds about 82.23 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96. | |
| PharmaCyte Biotech has a poor financial position based on the latest SEC disclosures |
PharmaCyte Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PharmaCyte Stock often depends not only on the future outlook of the current and potential PharmaCyte Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PharmaCyte Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.5 M | |
| Cash And Short Term Investments | 68 M |
PharmaCyte Biotech Technical Analysis
PharmaCyte Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. PharmaCyte Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PharmaCyte Biotech. In general, you should focus on analyzing PharmaCyte Stock price patterns and their correlations with different microeconomic environments and drivers.
PharmaCyte Biotech Predictive Forecast Models
PharmaCyte Biotech's time-series forecasting models is one of many PharmaCyte Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary PharmaCyte Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about PharmaCyte Biotech
Checking the ongoing alerts about PharmaCyte Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for PharmaCyte Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| PharmaCyte Biotech is not yet fully synchronised with the market data | |
| PharmaCyte Biotech has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (4.32 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PharmaCyte Biotech currently holds about 82.23 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96. | |
| PharmaCyte Biotech has a poor financial position based on the latest SEC disclosures |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the PharmaCyte Biotech information on this page should be used as a complementary analysis to other PharmaCyte Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Tools for PharmaCyte Stock
When running PharmaCyte Biotech's price analysis, check to measure PharmaCyte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaCyte Biotech is operating at the current time. Most of PharmaCyte Biotech's value examination focuses on studying past and present price action to predict the probability of PharmaCyte Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaCyte Biotech's price. Additionally, you may evaluate how the addition of PharmaCyte Biotech to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |